European Journal of Clinical Pharmacology

, Volume 64, Issue 2, pp 115–125

Do we learn the right things from clinical trials?

Authors

    • “Mario Negri” Institute for Pharmacological Research
  • Vittorio Bertele’
    • “Mario Negri” Institute for Pharmacological Research
Review Article

DOI: 10.1007/s00228-007-0411-4

Cite this article as:
Garattini, S. & Bertele’, V. Eur J Clin Pharmacol (2008) 64: 115. doi:10.1007/s00228-007-0411-4

Keywords

Added valueAdverse reactionsClinical end-pointsClinical drug trialsComparatorsDesignConflicts of interestRandomization

Copyright information

© Springer-Verlag 2007